Skip to main content

Find Clinical Trials

Home
Conditions
Histiocytosis

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

396 public trials 79 recruiting studies

Refine in advanced search Browse all conditions

Histiocytosis trial results

Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: LLC ARENSIA Exploratory Medicine Tbilisi, Georgia

IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova

Hospital Beata Maria Ana Madrid, Spain

Hospital Fundación Jiménez Diaz Madrid, Spain

View Trial Details

Recruiting

CAR-T Followed by Bispecific Antibodies

NCT04889716

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

NCT07249905

Conditions: Blood Protein Disorders, Cardiovascular Diseases, DLBCL - Diffuse Large B Cell Lymphoma, +28 more
Locations: Epworth HealthCare Richmond, Victoria, Australia

Linear Clinical Research Nedlands, Western Australia, Australia

View Trial Details

Recruiting

Prospective Cohort for Adult Hemophagocytosis

NCT03117010

Conditions: Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +3 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Recruiting

Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)

NCT05762640

Conditions: Haemophagocytic Lymphohistiocytosis, Hemic and Lymphatic Diseases, Histiocytosis, +3 more
Locations: Hopital Necker Enfants malades Paris, Île-de-France Region, France

View Trial Details

Recruiting

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

NCT07548697

Conditions: B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

NCT07545473

Conditions: Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +44 more
Locations: The Centre for Eye Research Australia Melbourne, Victoria, Australia

View Trial Details

Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations: Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

The University of Kansas Cancer Center Fairway, Kansas, United States

Rutgers Cancer Institute New Brunswick, New Jersey, United States

View Trial Details

Recruiting

Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

NCT07525466

Conditions: Extranodal NK T Cell Lymphoma, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis (HLH), +10 more
Locations: Beijing Tongren Hospital, Capital Medical University Beijing, China

View Trial Details

Recruiting

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

NCT06582745

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Cook Children's Health Care System Fort Worth, Texas, United States

View Trial Details